Abstract |
Recurrent thromboembolism despite oral anticoagulation is primarily suspicious of overt or occult neoplasia. We report on a man (age: 67 years) who presented with severe thrombophilia which was only controlled when the patient was set on a combined anticoagulation with low molecular weight heparin in supratherapeutic dosage and phenprocoumon with a target INR of 2.0. Despite repeated evaluation over about two years, a malignant tumour could never be demonstrated. However, the patient suffered in addition to a protein S deficiency from an antiphosphospholipid syndrome and a chronic myelomonocytic leukaemia. We postulate that the accepted strong thrombogenicity of antiphosphospholipid syndrome was further increased by protein S deficiency and a possibly procoagulatory effect of the abnormal monocytes explaining the severe thrombophilia resistant to standard therapeutic anticoagulation with a vitamin K antagonist and usual therapeutic doses of low molecular weight heparin, respectively.
|
Authors | J Bösiger, F Demarmels Biasiutti |
Journal | Hamostaseologie
(Hamostaseologie)
Vol. 23
Issue 3
Pg. 131-4
(Aug 2003)
ISSN: 0720-9355 [Print] Germany |
PMID | 12923583
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Anticoagulants
- Heparin, Low-Molecular-Weight
- Phenprocoumon
|
Topics |
- Aged
- Anticoagulants
(therapeutic use)
- Antiphospholipid Syndrome
(blood, diagnostic imaging)
- Blood Coagulation Tests
- Heparin, Low-Molecular-Weight
(therapeutic use)
- Humans
- Male
- Phenprocoumon
(therapeutic use)
- Pulmonary Embolism
(blood, diagnostic imaging, drug therapy)
- Recurrence
- Thrombosis
(blood, chemically induced, diagnostic imaging)
- Tomography, X-Ray Computed
|